DNASE1 and ischemic stroke: Thus, the combination of the tissue plasminogen activator and DNAse I demonstrated greater efficacy in thrombus lysis, just as it was suggested that the addition of DNAse I to DNA-poor thrombi, such as those obtained from patients with ischemic stroke, is not sufficient to lyse the thrombus.